Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, randomizované kontrolované studie, multicentrická studie
- Klíčová slova
- brain, infarction, ischemia, stroke, thrombectomy,
- MeSH
- endovaskulární výkony metody MeSH
- ischemická cévní mozková příhoda * chirurgie diagnostické zobrazování MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- trombektomie * metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: Recent randomized trials demonstrated the beneficial effect of endovascular therapy in patients with low Alberta Stroke Program Early CT Score. Despite large follow-up infarct volumes, a significantly increased rate of good functional outcomes was observed, challenging the role of infarct volume as a predictive imaging marker. This analysis evaluates the extent to which the effects of endovascular thrombectomy on functional outcomes are explained by (1) follow-up infarct volume and (2) early neurological status in patients with stroke with low Alberta Stroke Program Early CT Score. METHODS: TENSION (Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window) was a randomized trial conducted from February 2018 to January 2023 across 41 stroke centers. Two hundred fifty-three patients with ischemic stroke due to anterior circulation large vessel occlusion and Alberta Stroke Program Early CT Score of 3 to 5 were randomized to endovascular thrombectomy plus medical treatment or medical treatment alone. All patients with the availability of relevant data points were included in this secondary as-treated analysis. The primary outcome was the 90-day modified Rankin Scale score. Confounder-adjusted mediation analysis was performed to quantify the proportion of the treatment effect on a 90-day modified Rankin Scale score explained by (1) 24-hour follow-up infarct volume and (2) 24-hour National Institutes of Health Stroke Scale scores. RESULTS: One hundred eighty-eight patients were included; thereof, 87 (46%) were female patients. Median age was 72 (interquartile range, 63-79) years. The endovascular thrombectomy cohort had a 20.5 (95% CI, 8.3-33.7) percentage points higher probability of achieving independent ambulation (modified Rankin Scale, 0-3) and a 24.2 (95% CI, 13.4-35.8) percentage points lower mortality at 90 days compared with medical treatment alone. The reduction in 24-hour follow-up infarct volume explained 30% of the treatment effect on functional outcomes, while the 24-hour National Institutes of Health Stroke Scale score explained 61%. CONCLUSIONS: In patients with low Alberta Stroke Program Early CT Score, infarct volume demonstrated limited explanatory power for functional outcomes compared with the early neurological status, which may more effectively reflect factors such as the involvement of specific brain regions, disruption of structural networks, and selective neuronal loss.
Clinic of Neurology Jessenius Faculty of Medicine Comenius University Martin Slovakia
Clinic of Radiology Jessenius Faculty of Medicine Comenius University Martin Slovakia
Department of Neurology Aarhus University Hospital Denmark
Department of Neurology Faculty Hospital Trnava Slovakia
Department of Neurology Hôpital Maison Blanche Université Reims Champagne Ardenne France
Department of Neurology Oslo University Hospital Norway
Department of Neuroradiology Aarhus University Hospital Denmark
Department of Neuroradiology Hôpital Maison Blanche Université Reims Champagne Ardenne France
Department of Neuroradiology Medical University Innsbruck Austria
Department of Neuroradiology Oslo University Hospital Norway
Department of Radiology Faculty Hospital Trnava Slovakia
Department of Vascular Neurology University Hospital Bonn Germany
Institut für Neuroradiologie Universitätsklinikum Frankfurt Frankfurt am Main Germany
Klinik für Diagnostische und Interventionelle Neuroradiologie Klinikum Bremen Mitte Bremen Germany
Klinik für Diagnostische und Interventionelle Neuroradiologie Universitätsklinikum Bonn Germany
Klinik für Neurologie Klinikum Bremen Mitte Bremen Germany
Klinik und Poliklinik für Neurologie Universitätsklinikum Hamburg Eppendorf Germany
Klinikum Dortmund gGmbH Klinikum der Universität Witten Herdecke Dortmund Germany
Laboratoire de Biométrie et Biologie Évolutive Université de Lyon Villeurbanne France
Neurologie Universitätsklinikum Heidelberg and Universität Heidelberg Germany
Neuroradiologie Universitätsklinikum Heidelberg and Universität Heidelberg Germany
Norwegian University of Science and Technology Trondheim Norway
Service de Biostatistique Hospices Civils de Lyon France
Vascular Neurology Research Group German Center for Neurodegenerative Diseases
Citace poskytuje Crossref.org